U.S. Stem Cells Market Size & Outlook, 2024-2030
U.S. stem cells market, 2018-2030 (US$M)
Related Markets
U.S. stem cells market highlights
- The U.S. stem cells market generated a revenue of USD 5,300.2 million in 2024 and is expected to reach USD 9,116.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 9.5% from 2025 to 2030.
- In terms of segment, adult stem cells was the largest revenue generating product in 2024.
- Induced Pluripotent Stem Cells is the most lucrative product segment registering the fastest growth during the forecast period.
Stem cells market data book summary
| Market revenue in 2024 | USD 5,300.2 million |
| Market revenue in 2030 | USD 9,116.5 million |
| Growth rate | 9.5% (CAGR from 2024 to 2030) |
| Largest segment | Adult stem cells |
| Fastest growing segment | Induced Pluripotent Stem Cells |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells |
| Key market players worldwide | Thermo Fisher Scientific Inc, STEMCELL Technologies, CellGenix, PromoCell GmbH, Takara Bio Inc, Lonza Group Ltd, ATCC, Bio-Techne Corp |
Other key industry trends
- In terms of revenue, U.S. accounted for 32.1% of the global stem cells market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. stem cells market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 3,279.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Stem Cells Market Scope
Stem Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. stem cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stem cells market will help companies and investors design strategic landscapes.
Adult stem cells was the largest segment with a revenue share of 83.33% in 2024. Horizon Databook has segmented the U.S. stem cells market based on adult stem cells, human embryonic stem cells, induced pluripotent stem cells, very small embryonic like stem cells covering the revenue growth of each sub-segment from 2018 to 2030.
Availability of funds from government organizations significantly contributes to market growth in the U.S. The company plans to use these funds for expanding access to stem cell-derived therapies with an aim to develop the first independent human cell foundry by 2025.
The funds are expected to be used in expanding stem cell research at the facility. New projects planned with the funds include: Sanford Stem Cell Education and Integrated Space Stem Cell Orbital Research Program (ISSCOR),Sanford Stem Cell Fitness and Space Medicine Program, Sanford Stem Cell Accelerator.
Moreover, stem cell-based companies have received significant support during COVID-19 to develop therapies. Hence, this eases the process of raising funds from retail investors. In 2021, there were approximately 40 listed companies on the NASDAQ, the U.S. stock market.
Reasons to subscribe to U.S. stem cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. stem cells market databook
-
Our clientele includes a mix of stem cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. stem cells market , including forecasts for subscribers. This country databook contains high-level insights into U.S. stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. stem cells market size, by product, 2018-2030 (US$M)
U.S. Stem Cells Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
